7 cases of nodular lymphocyte-predominant Hodgkin lymphoma
10.3760/cma.j.issn.1009-9921.2010.10.014
- VernacularTitle:结节性淋巴细胞为主型霍奇金淋巴瘤七例
- Author:
Lu HUANG
;
Yunhong HUANG
- Publication Type:Journal Article
- Keywords:
Nodular lymphocyte-predominant Hodgkin lymphoma;
Diagnosis;
Therapy
- From:
Journal of Leukemia & Lymphoma
2010;19(10):618-619
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the clinicopathological characteristics and treatment of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL). Methods Seven patients were confirmed as NLPHL by pathologic immunohistochemistry. Six patients received combined-modality therapy of chemotherapy and involved field, and the other one received single chemotherapy. Results The 3-year local control rate and overall survival rate were 100 % and 86 %, respectively. Only one case died of pulmonary infection following chemotherapy. Conclusion These patients with NLPHL has favorable prognosis, tolerance and less toxicity for combined-modality therapy. However the management of toxicity following treatment should be noted.
